https://arstechnica.com/science/2023/01/fda-approves-new-alzheimers-treatment-despite-risks-unclear-benefits/
0
0
1/6/23 at 10:29pm
Organization
Ars Technica
Author
Beth Mole
25 words
0
Comments
The drug's price has already been set at $26,500 per year.
You are the first to view
Create an account
or login to join the discussion